Nancy Elizabeth Brutsche
Advanced Practice Registered Nurse, Psychiatric-Mental Health Clinical Nurse Specialist, and Psychotherapist
Data updated
Research Footprint
Nancy Elizabeth Brutsche appears in 7 tracked papers (2010–2018), most studied alongside Ketamine and Placebo, across Depressive Disorders, Major Depressive Disorder (MDD) and Bipolar Disorder.
Most-cited paper: A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression (967 citations).
Frequent co-authors: Carlos Zarate, David Luckenbaugh and Mark John Niciu.
Background & Research
Nancy E. Brutsche is a psychiatric nurse and psychotherapist who spent decades at the National Institutes of Health/National Institute of Mental Health working in psycho-neurobiological clinical research. Her publications include multiple influential ketamine studies on antidepressant response, dissociation, suicidal ideation, and biomarker-related outcomes. She later continued clinical work in psychotherapy and mindfulness-based practice in the Bethesda, Maryland area.
Key Impact
She is a key clinical researcher on early ketamine trials in treatment-resistant depression and suicidality, helping establish foundational evidence for rapid-acting antidepressant effects in psychiatric research.
Collaboration Network
11 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Nancy Elizabeth Brutsche is associated with.
National Institute of Mental Health (NIMH)
governmentU.S. federal institute defining mental-health research agendas and evidence-generation priorities including psychedelic-relevant studies.
View stakeholder →National Institutes of Health (NIH)
U.S. federal biomedical research agency shaping institute-level priority and research funding architecture.
View stakeholder →